Colorectal cancer-specific cytochrome P450 2W1: Intracellular localization, glycosylation, and catalytic activity

Molecular Pharmacology

Volumn 78, Issue 6, 2010, Pages 1004-1011

  Gomez, Alvin ^a,c   Nekvindova, Jana ^a,d   Travica, Sandra ^a   Lee, Mi Young ^a   Johansson, Inger ^a   Edler, David ^b   Mkrtchian, Souren ^a   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CYTOCHROME P450; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE;

ARTICLE; BIOINFORMATICS; CANCER TISSUE; CATALYSIS; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL SURFACE; CELLULAR DISTRIBUTION; COLON CANCER; COLORECTAL CANCER; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENE MUTATION; GLYCOSYLATION; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY CELL; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN METABOLISM;

AFLATOXIN B1; ASPARAGINE; BIOTRANSFORMATION; CACO-2 CELLS; CATALYTIC DOMAIN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRON-TRANSFERRING FLAVOPROTEINS; GLYCOSYLATION; HEK293 CELLS; HEP G2 CELLS; HUMANS; INDOLES; INTRACELLULAR FLUID;

EID: 78649931848     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.067652     Document Type: Article

References (31)

1. Aguiar M, Masse R, and Gibbs BF (2005) Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev 37:379-404. (Pubitemid 40677509)
2. Bruno RD and Njar VC (2007) Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem 15:5047-5060.
3. Bui PH and Hankinson O (2009) Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Mol Pharmacol 76:1031-1043.
4. Cepa M, Correia-da-Silva G, da Silva EJ, Roleira FM, Borges M, and Teixeira NA (2008) New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death. BMC Cell Biol 9:41.
5. Chen CS, Jounaidi Y, and Waxman DJ (2005) Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450. Drug Metab Dispos 33:1261-1267.
6. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, and Schenkman JB (2005) Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys 436:50-61.
7. Edler D, Stenstedt K, Ohrling K, Hallström M, Karlgren M, Ingelman-Sundberg M, and Ragnhammar P (2009) The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot study. Eur J Cancer 45:705-712.
8. Eliasson E and Kenna JG (1996) Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50:573-582.
9. Gladysheva IP, King SM, and Houng AK (2008) N-glycosylation modulates the cell-surface expression and catalytic activity of corin. Biochem Biophys Res Commun 373:130-135.
10. Gomez A, Karlgren M, Edler D, Bernal ML, Mkrtchian S, and Ingelman-Sundberg M (2007) Expression of CYP2W1 in colon tumors: regulation by gene methylation. Pharmacogenomics 8:1315-1325.
11. Ingelman-Sundberg M and Johansson I (1984) Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. J Biol Chem 259:6447-6458.
12. Karlgren M, Gomez A, Stark K, Svärd J, Rodriguez-Antona C, Oliw E, Bernal ML, Ramón y Cajal S, Johansson I, and Ingelman-Sundberg M (2006) Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem Biophys Res Commun 341:451-458.
13. Karlgren M, Miura S, and Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 207 (2 Suppl):57-61.
14. Loeper J, Descatoire V, Maurice M, Beaune P, Belghiti J, Houssin D, Ballet F, Feldmann G, Guengerich FP, and Pessayre D (1993) Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104:203-216.
15. McFadyen MC and Murray GI (2008) The CYP1B subfamily, in Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics (Ioannides C ed) pp 136-149, RSC Pub, Cambridge.
16. Medzihradszky KF (2008) Characterization of site-specific N-glycosylation. Methods Mol Biol 446:293-316.
17. Mkrtchian S, Fang C, Hellman U, and Ingelman-Sundberg M (1998) A stress-inducible rat liver endoplasmic reticulum protein, ERp29. Eur J Biochem 251:304-313. (Pubitemid 28080927)
18. Neve EP and Ingelman-Sundberg M (2000) Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. J Biol Chem 275:17130-17135.
19. Neve EP and Ingelman-Sundberg M (2010) Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum. Curr Opin Drug Discov Devel 13:78-85.
20. Nickson P, Toth A, and Erhardt P (2007) PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res 73:48-56.
21. Nishida CR, Lee M, and de Montellano PR (2010) Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 78:497-502.
22. Omura T (2006) Mitochondrial P450s. Chem Biol Interact 163:86-93.
23. Pahan K, Smith BT, Singh AK, and Singh I (1997) Cytochrome P-450 2E1 in rat liver peroxisomes: downregulation by ischemia/reperfusion-induced oxidative stress. Free Radic Biol Med 23:963-971.
24. Parkin DM, Bray F, Ferlay J, and Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
25. Rodriguez-Antona C, Gomez A, Karlgren M, Sim SC, and Ingelman-Sundberg M (2010) Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum Genet 127:1-17.
26. Ronis MJ, Johansson I, Hultenby K, Lagercrantz J, Glaumann H, and Ingelman-Sundberg M (1991) Acetone-regulated synthesis and degradation of cytochrome P450E1 and cytochrome P4502B1 in rat liver [published erratum appears in Eur J Biochem 200:812]. Eur J Biochem 198:383-389.
27. Sun H, Ehlhardt WJ, Kulanthaivel P, Lanza DL, Reilly CA, and Yost GS (2007) Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process. J Pharmacol Exp Ther 322:843-851.
28. Szczesna-Skorupa E, Chen CD, Rogers S, and Kemper B (1998) Mobility of cytochrome P450 in the endoplasmic reticulum membrane. Proc Natl Acad Sci USA 95:14793-14798.
29. Walsh G and Jefferis R (2006) Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 24:1241-1252.
30. Wu ZL, Sohl CD, Shimada T, and Guengerich FP (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007-2014.
31. Yoshioka H, Kasai N, Ikushiro S, Shinkyo R, Kamakura M, Ohta M, Inouye K, and Sakaki T (2006) Enzymatic properties of human CYP2W1 expressed in Escherichia coli. Biochem Biophys Res Commun 345:169-174.